SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-17-013397
Filing Date
2017-12-19
Accepted
2017-12-19 08:35:46
Documents
2
Period of Report
2017-12-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k121917_immucellcorp.htm 8-K 31938
2 PRESS RELEASE OF IMMUCELL CORPORATION, DATED DECEMBER 19, 2017 f8k121917ex99-1_immucellcorp.htm EX-99.1 23987
  Complete submission text file 0001213900-17-013397.txt   57121
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12934 | Film No.: 171262845
SIC: 2835 In Vitro & In Vivo Diagnostic Substances